Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 24 | 28 | +4 |
| Shares | 2.56M | 2.83M | +268.2K (+10.5%) |
| Value | $34.5M | $29.1M | −$5.42M (−15.7%) |
New holders (4)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aspireon Wealth Advisors | 71,811 | $742.0K | 0.33% |
| Crossvault Capital Management LLC | 14,285 | $148.0K | 0.06% |
| Islay Capital Management, LLC | 9,611 | $99.0K | 0.10% |
| Canton Hathaway, LLC | 8,600 | $89.0K | 0.03% |
Sold out (0)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
None.